Investment Summary |
|
|---|---|
| Date | 2017-01-02 |
| Target | BridgeBio |
| Sector | Life Science |
| Investor(s) |
Aisling Capital
KKR Athyrium Capital Management |
| Deal Type | PIPE |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 1.8B USD |
| Size | Large |
| Type | Sector Focused |
Aisling Capital is a private investment firm focused on opportunities in the healthcare and medical technology sectors. The Firm specifically looks to invest in companies developing and commercializing innovative healthcare products, services, and technologies. Aisling Capital looks to commit $20 to $50 million per investment and prefers to be the lead investor. Aisling will consider investing in both public and private companies. Aisling Capital raised its first fund in 2000. The Firm is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 39 of 56 |
| Sector: Life Science M&A | 28 of 42 |
| Type: PIPE M&A Deals | 4 of 12 |
| State: California M&A | 10 of 15 |
| Country: United States M&A | 37 of 52 |
| Year: 2017 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-01 |
Ajax Health
Menlo Park, California, United States Ajax focuses on accelerating innovative medical device technology opportunities that address significant unmet clinical needs. Ajax Health was formed in 2017 and is based in Menlo Park, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-02-13 |
ZELTIQ Aesthetics
Pleasanton, California, United States ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to reduce unwanted fat. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. |
Sell | $2.5B |
| Category | Private Equity Firm |
|---|---|
| Founded | 1976 |
| PE ASSETS | 267.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
KKR is a global investment firm founded by Jerome Kohlberg, Henry Kravis, and George Roberts. The Firm is separated into several business segments including private markets, public markets, capital markets, and other principal activities. KKR's private equity practice invests in management buyouts, take privates, corporate divestitures, industry consolidations, and partnerships with family-owned companies. KKR will invest in a broad range of industries and companies and will consider businesses throughout North America, Europe, Asia, and Australia/New Zealand. Sectors of interest include chemicals, consumer products, energy and natural resources, financial services, healthcare, industrial, media/communications, retail, and technology. In addition to its traditional principal investment activity business, KKR also invests in infrastructure assets. KKR was formed in 1976 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 223 of 499 |
| Sector: Life Science M&A | 9 of 21 |
| Type: PIPE M&A Deals | 13 of 15 |
| State: California M&A | 18 of 46 |
| Country: United States M&A | 94 of 212 |
| Year: 2017 M&A | 3 of 41 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-01 |
Ajax Health
Menlo Park, California, United States Ajax focuses on accelerating innovative medical device technology opportunities that address significant unmet clinical needs. Ajax Health was formed in 2017 and is based in Menlo Park, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-05 |
Slayback Pharma
Princeton, New Jersey, United States Slayback Pharma is a specialty pharmaceutical company focused on developing, manufacturing, and sourcing complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. Slayback Pharma was founded in 2011 and is based in Princeton, New Jersey. |
Buy | - |
| Category | Asset Manager |
|---|---|
| Founded | 2008 |
| PE ASSETS | 4.6B USD |
| Size | Large |
| Type | Sector Focused |
Athyrium Capital Management is a large asset manager focused on the healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations. Athyrium Capital was established in 2008 and is headquartered in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 22 of 50 |
| Sector: Life Science M&A | 13 of 24 |
| Type: PIPE M&A Deals | 2 of 3 |
| State: California M&A | 6 of 9 |
| Country: United States M&A | 20 of 45 |
| Year: 2017 M&A | 1 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-10-31 |
Team Health
Knoxville, Tennessee, United States Team Health is a provider of outsourced healthcare professional staffing and administrative services to hospitals and other healthcare providers in the United States. Team Health was founded in 1979 and is based in Knoxville, Tennessee. |
Buy | $6.1B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-02-02 |
IMC Health Medical Centers
Miami Lakes, Florida, United States IMC Health Medical Centers is a provider of primary care and specialty services to Medicare, Medicaid and commercial populations through 19 medical centers in Florida. IMC delivers high-quality medical care to thousands of members for numerous managed care organizations. IMC Health Medical Centers was founded in 2004 and is based in Miami Lakes, Florida. |
Buy | - |
